Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tubal Carcinoma”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Early research (Phase 1)Study completedNCT00003385
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 48
Early research (Phase 1)Ended earlyNCT00003380
What this trial is testing

Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)UnknownNCT00003634
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AltaRex 400
Testing effectiveness (Phase 2)UnknownNCT01180504
What this trial is testing

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma
University Hospital Heidelberg 36
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Ended earlyNCT03100006
What this trial is testing

Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 13
Testing effectiveness (Phase 2)Study completedNCT00181688
What this trial is testing

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CarcinomaTubal Carcinoma
Massachusetts General Hospital 35
Not applicableStudy completedNCT03593681
What this trial is testing

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

Who this might be right for
Fallopian Tube CancerOvarian CancerOvarian Neoplasms+8 more
Boston Scientific Corporation 150
Not applicableStudy completedNCT06599749
What this trial is testing

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

Who this might be right for
Adenocarcinoma of OvaryAdenocarcinoma, TubularPeritoneal Cancer
University Hospital, Basel, Switzerland 80
Not applicableStudy completedNCT02518256
What this trial is testing

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity

Who this might be right for
Ovarian Epithelial Cancer
Medical University of Vienna 270
Testing effectiveness (Phase 2)Study completedNCT03480750
What this trial is testing

Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasms Malignant (Excl Germ Cell)Peritoneal CarcinomaFallopian Tube Cancer
National Cheng-Kung University Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Not applicableEnded earlyNCT03922776
What this trial is testing

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IV+1 more
Centre Oscar Lambret 36
Not applicableStudy completedNCT02221076
What this trial is testing

Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.

Who this might be right for
Cervix CancerEndometrium CancerOvarian Cancer+1 more
Mauna Kea Technologies 16
Early research (Phase 1)Study completedNCT00003967
What this trial is testing

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00157573
What this trial is testing

GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube Cancer
Massachusetts General Hospital 72
Large-scale testing (Phase 3)Study completedNCT03598270
What this trial is testing

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Carcinoma
Grupo Español de Investigación en Cáncer de Ovario 417
Not applicableStudy completedNCT02039388
What this trial is testing

Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma

Who this might be right for
Ovarian Epithelial CancerCarcinoma in SituOvarian Cancer
Medical University of Vienna 701
Early research (Phase 1)Study completedNCT00352300
What this trial is testing

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Who this might be right for
Fallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more
Gynecologic Oncology Group 43
Load More Results